A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
Clinical trial NCT00730275 · COMPLETED
Trial details
- NCT number
- NCT00730275
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-18
- Primary completion
- 2010-12-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.